Compare PFE & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PFE | MDT |
|---|---|---|
| Founded | 1849 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.4B | 125.3B |
| IPO Year | N/A | N/A |
| Metric | PFE | MDT |
|---|---|---|
| Price | $25.11 | $96.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 18 |
| Target Price | $27.40 | ★ $108.44 |
| AVG Volume (30 Days) | ★ 48.3M | 5.8M |
| Earning Date | 02-03-2026 | 11-18-2025 |
| Dividend Yield | ★ 6.86% | 2.94% |
| EPS Growth | ★ 131.89 | 12.98 |
| EPS | 1.73 | ★ 3.69 |
| Revenue | ★ $62,785,000,000.00 | $34,758,000,000.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | N/A | $5.86 |
| P/E Ratio | ★ $14.58 | $26.16 |
| Revenue Growth | 3.89 | ★ 5.34 |
| 52 Week Low | $20.92 | $79.29 |
| 52 Week High | $27.69 | $106.33 |
| Indicator | PFE | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 38.22 |
| Support Level | $24.83 | $96.89 |
| Resistance Level | $25.52 | $99.26 |
| Average True Range (ATR) | 0.54 | 1.34 |
| MACD | -0.10 | -0.60 |
| Stochastic Oscillator | 11.81 | 6.58 |
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.